Literature DB >> 9544741

Characterization of atherosclerotic lesions in apo E3-leiden transgenic mice.

P Leppänen1, J S Luoma, M H Hofker, L M Havekes, S Ylä-Herttuala.   

Abstract

Apo E3-leiden transgenic mice express human dysfunctional apo E variant and develop hyperlipidemia and atherosclerosis on a high fat/high cholesterol diet. We characterized diet-induced atherosclerotic lesions in apo E3-leiden transgenic mice using immunocytochemical methods in order to examine foam cell formation and determine whether advanced atherosclerotic lesions develop in these animals. Special attention was given to the presence of oxidized lipoproteins and expression of lipoprotein receptors. Plasma cholesterol levels in apo E3-leiden mice on an atherogenic diet increased from 2 to 36 mmol/l in 4 months. At this time apo E3-leiden mice had developed lesions, which ranged from early fatty streaks in thoracic and abdominal aorta to advanced lesions in aortic arch. Early fatty streaks were entirely composed of macrophages which also expressed scavenger receptors. Epitopes characteristic of oxidized LDL were present in macrophage-rich foam cells. Advanced atherosclerotic lesions also developed in apo E3-leiden mice including smooth muscle cell cap formation and erosion of the media. Macrophages and epitopes characteristic of oxidized LDL were present in core and shoulder regions. Scavenger receptors were expressed in macrophages in advanced lesions, whereas LDL-receptor-related protein (LRP) was mainly expressed in smooth muscle cells. It is concluded that: (1) macrophages are the major cell type in both early and advanced atherosclerotic lesions; (2) scavenger receptors and oxidized lipoproteins are present in lesion macrophages; and (3) LRP is mostly expressed in smooth muscle cells. Thus, lesions in apo E3-leiden transgenic mice have features in common with human atherosclerosis. Since lesion macrophages also retain their ability to synthesize endogenous apo E, apo E3-leiden transgenic mouse may be a useful model for studies on the development and genetics of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9544741     DOI: 10.1016/s0021-9150(97)00196-2

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  8 in total

Review 1.  Hyperlipidaemia and cardioprotection: Animal models for translational studies.

Authors:  Ioanna Andreadou; Rainer Schulz; Lina Badimon; Adriana Adameová; Petra Kleinbongard; Sandrine Lecour; Panagiota-Efstathia Nikolaou; Ines Falcão-Pires; Gemma Vilahur; Nicholas Woudberg; Gerd Heusch; Péter Ferdinandy
Journal:  Br J Pharmacol       Date:  2020-01-17       Impact factor: 8.739

2.  Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice.

Authors:  U Schönbeck; G K Sukhova; K Shimizu; F Mach; P Libby
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

Review 3.  The mechanisms of coronary restenosis: insights from experimental models.

Authors:  G A Ferns; T Y Avades
Journal:  Int J Exp Pathol       Date:  2000-04       Impact factor: 1.925

4.  Enhanced polyamine catabolism alters homeostatic control of white adipose tissue mass, energy expenditure, and glucose metabolism.

Authors:  Eija Pirinen; Teemu Kuulasmaa; Marko Pietilä; Sami Heikkinen; Maija Tusa; Paula Itkonen; Susanna Boman; Joanna Skommer; Antti Virkamäki; Esa Hohtola; Mikko Kettunen; Szabolcs Fatrai; Emilia Kansanen; Suvi Koota; Kirsi Niiranen; Jyrki Parkkinen; Anna-Liisa Levonen; Seppo Ylä-Herttuala; J Kalervo Hiltunen; Leena Alhonen; Ulf Smith; Juhani Jänne; Markku Laakso
Journal:  Mol Cell Biol       Date:  2007-05-07       Impact factor: 4.272

5.  Oxidized LDL activates fas-mediated endothelial cell apoptosis.

Authors:  M Sata; K Walsh
Journal:  J Clin Invest       Date:  1998-11-01       Impact factor: 14.808

6.  A new mouse mutant for the LDL receptor identified using ENU mutagenesis.

Authors:  Karen L Svenson; Nadav Ahituv; Rebecca S Durgin; Holly Savage; Phyllis A Magnani; Oded Foreman; Beverly Paigen; Luanne L Peters
Journal:  J Lipid Res       Date:  2008-07-15       Impact factor: 5.922

Review 7.  Animal models of cardiovascular diseases.

Authors:  Carlos Zaragoza; Carmen Gomez-Guerrero; Jose Luis Martin-Ventura; Luis Blanco-Colio; Begoña Lavin; Beñat Mallavia; Carlos Tarin; Sebastian Mas; Alberto Ortiz; Jesus Egido
Journal:  J Biomed Biotechnol       Date:  2011-02-16

Review 8.  Mouse models of atherosclerosis and their suitability for the study of myocardial infarction.

Authors:  Pelin Golforoush; Derek M Yellon; Sean M Davidson
Journal:  Basic Res Cardiol       Date:  2020-11-30       Impact factor: 17.165

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.